Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,280Revenue $M0.0Net Margin (%)0Z-Score-7.6
Enterprise Value $M3,418EPS $-0.6Operating Margin %0F-Score4
P/E(ttm))0Cash Flow Per Share $-1.1Pre-tax Margin (%)0Higher ROA y-yY
Price/Book16910-y EBITDA Growth Rate %-18.8Quick Ratio0.9Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-26.5Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-74.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M389ROI % (ttm)-83.8Gross Margin Increase y-yN

Gurus Latest Trades with MNKD

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MNKDJean-Marie Eveillard 2013-03-31 Sold Out -0.01%$2.31 - $3.56
($2.75)
$ 8.81220%Sold Out0
MNKDJean-Marie Eveillard 2012-12-31 Buy 0.01%$1.85 - $2.83
($2.16)
$ 8.81308%New holding, 800000 sh.800,000
MNKDGeorge Soros 2007-09-30 Sold Out -0.01%$8.87 - $13.09
($10.2)
$ 8.81-14%Sold Out0
MNKDGeorge Soros 2007-06-30 Buy 0.01%$11.46 - $14.95
($13.3)
$ 8.81-34%New holding, 13493 sh.13,493
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MNKD is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


MNKD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Martens JuergenCorporate VP 2014-07-21Sell26,458$9.65-6.74 view
Thomson DavidVP & General Counsel 2014-07-17Sell30,000$9.42-4.46 view
Palumbo DianeVice President, Human Resource 2014-07-15Sell17,901$10.01-10.09 view
PFEFFER MATTHEW JCorporate VP and CFO 2014-07-01Sell20,000$10.44-13.79 view
PFEFFER MATTHEW JCorporate VP and CFO 2014-06-30Buy527$4.42103.62 view
Edstrom HakanPresident & COO 2014-06-30Buy1,692$4.42103.62 view
Palumbo DianeVice President, Human Resource 2014-06-30Buy636$4.42103.62 view
Martens JuergenCorporate VP 2014-06-27Sell25,417$10.53-14.53 view
Thomson DavidVP & General Counsel 2014-06-26Sell30,000$10.51-14.37 view
Martens JuergenCorporate VP 2014-06-20Sell1,458$10.34-12.96 view

Press Releases about MNKD :

    Quarterly/Annual Reports about MNKD:

    News about MNKD:

    Articles On GuruFocus.com
    MannKind Corporation: Investors Should Seek Truth As The Requisite To Finding This Alpha Jul 24 2014 
    Recent Tsunami of Insider Shares Purchased: A Prelude To Mannkind Partnership or Acquisition Jul 19 2014 
    Mannkind Corporation: Why Afrezza Would Completely Dominate The Insulin Market Jul 16 2014 
    A Look at Mannkind Corporation's True Value Jul 02 2014 
    Time to Gamble on MannKind’s Afrezza Mar 27 2014 
    MannKind Corporation: Will It Make It to the Promised Land? Mar 17 2014 
    Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    The Details of the Afrezza Approval Delay Jan 31 2012 
    MannKind’s Afrezza Was to Be Approved; What Happened Next? Jan 30 2012 


    More From Other Websites
    Business Highlights Jul 24 2014
    Hedge fund: This 'mania' health stock will fall 90% Jul 24 2014
    MANNKIND CORP Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under... Jul 22 2014
    Top Swing Trade Ideas for Monday July 21: Cliffs Natural Resources, MannKind, PolyOne Jul 21 2014
    Fed Chair Yellen Says Small Biotech Stocks Over-Valued Jul 15 2014
    MannKind: Are These Top Big Pharma Companies Potential Partners? Jul 14 2014
    Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events Jul 14 2014
    MannKind (MNKD) Stock Continues to Decline Wednesday Jul 02 2014
    MannKind Poll Points to Bias That Stock Will Rise Above $15 into 2015 Jul 02 2014
    Time to take profits in MannKind, Barron's says Jul 01 2014
    [$$] MannKind: Take the Money and Run Very Fast Jul 01 2014
    MannKind Is Still a Risky Investment Even With FDA Approval Jul 01 2014
    Why The Market Is Giving MannKind A Reality Check Jul 01 2014
    Why ManKind (MNKD) Stock Is Falling Today Jul 01 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide